The company went public in May. Let's see what the charts tell us.
Why are the healthcare and utilities ETFs not going up now? Let's take a deep dive.
I didn't like it then and I don't like it now.
With two approaches on the same page, here's how we'd trade this drugmaker's stock.
LifeMD had one of the best quarters among my small cap holdings this earnings season -- let's see how to trade the telehealth name.
The advance is looking mature and a shift in strategy may be called for.
Unbelievably, there may be more interest in weight loss than AI right now.
One earnings story that caught my eye was this pharmaceutical name.
Traders and investors should take appropriation action.
Here's how traders can play the stock.